206 articles
The Delhi High Court analysed whether Natco Pharma’s process infringed FMC Corporation’s patented method for producing chlorantraniliprole. The court, relying on expert opinions, found key differences in process…
This post analyses recent Indian patent cases from 2022, focusing on notable court decisions such as MSN Laboratories v. Novartis Ag. It provides legal insights into patent infringement…
This week’s bulletin highlights the absence of a single leader in 5G technology as found by the USPTO and the notification of key IPR rules by the Delhi…
The Delhi High Court ruled on a patent infringement dispute involving a self-propelled dolly for vehicle transfer in car parks. The Court found infringement despite technical differences and…
India has significantly increased its patent grants, while Purdue University has filed a patent infringement suit against Google. Other updates include Gilead’s settlement on HIV drug patents, BlackBerry’s…
This week’s patent news highlights the Supreme Court’s extension of limitation periods and Natco Pharma’s new license for Molnupiravir. Updates also include important patent litigation developments in India…
This article summarises pivotal Delhi High Court decisions on patent disputes in 2021, particularly involving pharmaceutical products. The analysis covers interim injunctions and key arguments in Indian patent…
Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates…
India and Japan will act as competent ISA and IPEA for each other's PCT filings from July 2021. Apple faces a $308.5 million patent infringement fine, while the…
China led in global patent filings for 2020, with India ranking 13th. Industry groups have raised concerns over the possible abolition of the IPAB. The post also covers…